Author: Andrés Pizzorno; Blandine Padey; Thomas Julien; Sophie Trouillet-Assant; Aurélien Traversier; Elisabeth Errazuriz-Cerda; Julien Fouret; Julia Dubois; Alexandre Gaymard; François-Xavier Lescure; Victoria Dulière; Pauline Brun; Samuel Constant; Julien Poissy; Bruno Lina; Yazdan Yazdanpanah; Olivier Terrier; Manuel Rosa-Calatrava
Title: Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia Document date: 2020_4_2
ID: bw9lbzvt_2
Snippet: As with most emerging viral diseases, no specific antiviral treatment nor vaccine against any of these three coronaviruses are currently available, with standard patient management relying 60 mainly on symptom treatment and respiratory support when needed. In that regard, and considering that key features of the biology of SARS-CoV-2 and its induced COVID-19 still require further characterization, the scarce readiness of biologically relevant pre.....
Document: As with most emerging viral diseases, no specific antiviral treatment nor vaccine against any of these three coronaviruses are currently available, with standard patient management relying 60 mainly on symptom treatment and respiratory support when needed. In that regard, and considering that key features of the biology of SARS-CoV-2 and its induced COVID-19 still require further characterization, the scarce readiness of biologically relevant pre-clinical experimental models of SARS-CoV-2 infection as a complement of the African green monkey VeroE6 cell line represents a major barrier for scientific and medical progress in this area. We and others have previously functional and innate immune features of the human respiratory epithelium that play a central role 70 in the early stages of infection and constitute robust surrogates to study airway disease mechanisms and for drug discovery (10).
Search related documents:
Co phrase search for related documents- african green monkey and cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- african green monkey and central role: 1
- african green monkey and early stage: 1, 2, 3
- african green monkey and green monkey: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- african green monkey and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- african green monkey and viral disease: 1, 2, 3
- airway disease and cell line: 1, 2, 3
- airway disease and central role: 1, 2, 3
- airway disease and early stage: 1
- airway disease and experimental model: 1, 2
- airway disease and human respiratory epithelium: 1
- airway disease and induced SARS: 1, 2
- airway disease and key feature: 1, 2
- airway disease and patient management: 1, 2, 3, 4
- airway disease and respiratory support: 1, 2, 3, 4, 5, 6
- airway disease and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- airway disease and viral disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- antiviral treatment and cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antiviral treatment and central role: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date